H-VVYDFLKC-OH

Ref. 3D-PP44257

Informations sur le produit

• Nom: H-VVYDFLKC-OH
• Synonymes: NH2-Val-Val-Tyr-Asp-Phe-Leu-Lys-Cys-OH

Description

Peptide H-VVYDFLKC-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VVYDFLKC-OH include the following: Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice TD Schell, LM Mylin, I Georgoff, AK Teresky - Journal of , 1999 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.73.7.5981-5993.1999 Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma S Stahl , T Sacher, A Bechtold, U Protzer , R Ganss - Immunology letters, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247809000157 Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantation R Hess Michelini , T Manzo , T Sturmheit, V Basso - Cancer research, 2013 - AACRhttps://aacrjournals.org/cancerres/article-abstract/73/15/4641/584297 Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors R Hess Michelini , M Freschi, T Manzo , E Jachetti - Cancer research, 2010 - AACRhttps://aacrjournals.org/cancerres/article-abstract/70/9/3505/567564 Anti-CD40 conditioning enhances the TCD8 response to a highly tolerogenic epitope and subsequent immunotherapy of simian virus 40 T antigen-induced pancreatic P Otahal, BB Knowles , SS Tevethia - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/179/10/6686/75587 Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity N Asprodites, L Zheng, D Geng - The FASEB , 2008 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2537425/ Androgen ablation augments human HLA2. 1-restricted T cell responses to PSA self-antigen in transgenic mice MS Arredouani, SS Tseng-Rogenski - The , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pros.21134 Avoiding tolerance against prostatic antigens with subdominant peptide epitopes ME Grossmann, E Davila, E Celis - Journal of Immunotherapy, 2001 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2001/05000/Avoiding_Tolerance_Against_Prostatic_Antigens_With.7.aspx Identification of mimotopes for the H4 minor histocompatibility antigen. MA Strausbauch , WK Nevala - International , 1998 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/10/4/421/667669 Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells M Tomasi , E Caproni, M Benedet, I Zanella - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2022.912639/full Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells M Bellone , Q Kong, AG Goubet, U Genacašve, G Grandi - academia.eduhttps://www.academia.edu/download/107857478/pdf.pdf Quantitation of CD8+ T-Lymphocyte Responses to Multiple Epitopes from Simian Virus 40 (SV40) Large T Antigen in C57BL/6 Mice Immunized with SV40, SV40 T LM Mylin, TD Schell, D Roberts, M Epler - Journal of , 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.15.6922-6934.2000 Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen LM Mylin, AM Deckhut, RH Bonneau, TD Kierstead - Virology, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682285711397 Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers JE Blaney Jr, E Nobusawa, MA Brehm - Journal of , 1998 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.72.12.9567-9574.1998 CD8+ T-cell cross-competition is governed by peptide-MHC class I stability I Galea , J Stasakova, MS Dunscombe - European journal of , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201142010 The impact of self-tolerance on the polyclonal CD8+ T cell repertoire HWHG Kessels, KE de Visser , FH Tirion - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/4/2324/71804 Generation of T cell help through a MHC class I-restricted TCR HWHG Kessels, K Schepers - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/2/976/37483 Immunization with a Single Major HC Class - J. Virol, 1998 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=967b59c772446bdec973b152e9f7f65a743bb784 Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL E Davila, E Celis - The Journal of Immunology, 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/1/539/33394 The Impact of Self-Tolerance on the CD Polyclonal - J Immunol, 2004 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=b49a673fe62cced2a86e591c588a4964a0e692c4 Boosting interleukin-12 antitumor activity and synergism with immunotherapy by targeted delivery with isoDGR-tagged nanogold AM Gasparri, A Sacchi, V Basso, F Cortesi, M Freschi - Small, 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/smll.201903462 Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A Textor, K Schmidt, PM Kloetzel, B Weissbrich - Journal of Experimental , 2016 - rupress.orghttps://rupress.org/jem/article-abstract/213/11/2333/41988 EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in mice A Rehm, A Wirges, D Hoser, C Fischer, S Herda - JCI insight, 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220939/

• Marque: Biosynth